The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that L’hôpital Universitaire Avicenne is implementing the SOPHiA DDM™ Platform. The hospital, located in Bobigny, France, will use the […]

OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that OncoHelix, an internationally recognized research and diagnostics laboratory for precision diagnostics, will implement MSK-ACCESS® powered with SOPHiA DDM™. The organization, which currently uses the SOPHiA […]

Highly Accurate Long-Read Sequencing Data Will Be Used At Novogene’s New Lab In Munich, Supporting Customers Across A Network Of Leading Research Institutions MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its […]

Multi-billion-dollar market cap customer targets scope 1 emissions reduction Combined with recent orders, this annual recurring revenue at full deployment has the potential to bring company to positive cash flow WATERTOWN, Mass. — Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire”), a pioneer in environmental measurement technology, is pleased to announce initial delivery of AireCore units to […]

Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from […]

Placement of the first firefly platform in Japan expands SPT Labtech’s growing global liquid handling community. Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, announces the selection of its firefly all-in-one liquid handling platform by PRISM BioLab, a leading discovery […]

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups OXFORD, England — Genomics plc (Genomics), a healthcare company transforming health through the power of genomics today announced a three-year extension of the company’s collaboration with Vertex Pharmaceuticals Incorporated (Vertex) (Nasdaq: VRTX) to […]

Cutting-edge biotech builds on best-in-class software to automate R&D workflows for designing novel drug candidates using machine learning approaches Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that BioCopy, a research-based biotechnology company and innovator in combining artificial intelligence with end-to-end automated protein engineering to generate safe […]

The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing + Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on […]

The Avance® 1.2 GHz NMR system will enable advanced studies of biomolecular structures and function in structural biology, pharmacology, and cellular biology BERLIN —  Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, accepted in the second quarter […]